BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Somaya Albhaisi, Arun J. Sanyal. Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to DatePharmaceutical Medicine 2019;  doi: 10.1007/s40290-019-00305-z
2
Zaki A. Sherif. Nonalcoholic Fatty Liver Disease - An Update [Working Title]2019;  doi: 10.5772/intechopen.85780
3
P.-Y. Brillet. Dépistage du cancer broncho-pulmonaire: les « big 3 » et les autresRevue des Maladies Respiratoires Actualités 2019; 11(2): 107 doi: 10.1016/S1877-1203(19)30041-2
4
Mercedes del Río-Moreno, Emilia Alors-Pérez, Sandra González-Rubio, Gustavo Ferrín, Oscar Reyes, Manuel Rodríguez-Perálvarez, Marina E Sánchez-Frías, Rafael Sánchez-Sánchez, Sebastián Ventura, José López-Miranda, Rhonda D Kineman, Manuel de la Mata, Justo P Castaño, Manuel D Gahete, Raúl M Luque. Dysregulation of the Splicing Machinery Is Associated to the Development of Nonalcoholic Fatty Liver DiseaseThe Journal of Clinical Endocrinology & Metabolism 2019; 104(8): 3389 doi: 10.1210/jc.2019-00021
5
Man Zhang. Imaging Biomarkers for Nonalcoholic Fatty Liver DiseaseAcademic Radiology 2019; 26(7): 869 doi: 10.1016/j.acra.2019.04.001
6
Zhen Huang, Lei‐Ming Wu, Jie‐Lei Zhang, Abdelkarim Sabri, Shou‐Jun Wang, Gui‐Jun Qin, Chang‐Qing Guo, Hong‐Tao Wen, Bin‐Bin Du, Dian‐Hong Zhang, Ling‐Yao Kong, Xin‐Yu Tian, Rui Yao, Ya‐Peng Li, Cui Liang, Peng‐Cheng Li, Zheng Wang, Jin‐Yan Guo, Ling Li, Jian‐Zeng Dong, Yan‐Zhou Zhang. Dual Specificity Phosphatase 12 Regulates Hepatic Lipid Metabolism Through Inhibition of the Lipogenesis and Apoptosis Signal–Regulating Kinase 1 PathwaysHepatology 2019; 70(4): 1099 doi: 10.1002/hep.30597
7
Andrew J. Krentz, Pierre Bedossa. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease2019; : 245 doi: 10.1007/978-3-030-11748-1_10
8
Stefano Ballestri, Fabio Nascimbeni, Simonetta Lugari, Amedeo Lonardo, Giampiero Francica. A critical appraisal of the use of ultrasound in hepatic steatosisExpert Review of Gastroenterology & Hepatology 2019; 13(7): 667 doi: 10.1080/17474124.2019.1621164
9
J.A. Weintraub, G. Lopez Mitnik, B.A. Dye. Oral Diseases Associated with Nonalcoholic Fatty Liver Disease in the United StatesJournal of Dental Research 2019; 98(11): 1219 doi: 10.1177/0022034519866442
10
Gerhard Nygaard. On a Novel, Simplified Model Framework Describing Ascorbic Acid Concentration Dynamics2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 2019; : 2880 doi: 10.1109/EMBC.2019.8857675
11
Niki Katsiki, Amalia Gastaldelli, Dimitri P. Mikhailidis. Predictive models with the use of omics and supervised machine learning to diagnose non-alcoholic fatty liver disease: A “non-invasive alternative” to liver biopsy?Metabolism 2019; : 154010 doi: 10.1016/j.metabol.2019.154010
12
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka. Current status, problems, and perspectives of non-alcoholic fatty liver disease researchWorld Journal of Gastroenterology 2019; 25(2): 163-177 doi: 10.3748/wjg.v25.i2.163
13
Jiajia Yang, Liwu Lin, Ensheng Xue, Dengke Hong, Yan Yang, Meifang Xu, Zhikui Chen. Can Nonfibrotic Nonalcoholic Steatohepatitis Be Effectively Identified by Supersonic Shear Imaging?Analytical Cellular Pathology 2019; 2019: 1 doi: 10.1155/2019/2013674
14
Ahmad Khonche, Hasan Fallah Huseini, Mahdi Gholamian, Reza Mohtashami, Farzaneh Nabati, Saeed Kianbakht. Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trialJournal of Ethnopharmacology 2019; 234: 106 doi: 10.1016/j.jep.2019.01.009